Use of multiple biomarkers for evaluation of anthracycline-induced cardiotoxicity in patients with acute myeloid leukemia

• Published in: Experimental Oncology
• Date: 2008
• Main Authors: Horacek, J.M., Tichy, M., Jebavy, L., Pudil, R., Ulrychova, M., Maly, J.
• Format: Article
• Language: English
• Published: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2008
• Subjects: Uncategorized
• Online Access: https://nasplib.isofts.kiev.ua/handle/123456789/139190
• Journal Title: Digital Library of Periodicals of National Academy of Sciences of Ukraine
• Cite this: Use of multiple biomarkers for evaluation of anthracycline-induced cardiotoxicity in patients with acute myeloid leukemia / J.M. Horacek, M. Tichy, L. Jebavy, R. Pudil, M. Ulrychova, J. Maly // Experimental Oncology. — 2008. — Т. 30, № 2. — С. 157–159. — Бібліогр.: 10 назв. — англ.

To assess cardiac toxicity of anthracycline treatment with six biomarkers of cardiac injury: myoglobin, creatine kinase MB (CK-MB mass), cardiac troponin T (cTnT), cardiac troponin I (cTnI), heart-type fatty acid binding protein (H-FABP), glycogen phosphorylase BB (GPBB). Methods: We evaluated anthr...